Many studies have reported the aberrant activation of JAK1 and STAT3 in the development of HCC which are the key members of the JAK/STAT signaling pathway and promote tumorigenesis (Hin Tang et al., 2020). The gene discussed is JAK1; the disease is hepatocellular carcinoma.